Northern Westchester Hospital — Mount Kisco, New York

Public research footprint of Northern Westchester Hospital, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Anatomic Stage II Breast Cancer AJCC v8 · Stage IB Lung Non-Small Cell Carcinoma AJCC v7 · Stage IIIA Lung Non-Small Cell Cancer AJCC v7 · Locally Advanced Renal Pelvis and Ureter Urothelial Carcinoma

Recently updated registry entries

NCT07232069 — PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis (Recruiting)
NCT06058377 — Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment… (Recruiting)
NCT07061977 — Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Northern Westchester Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.